Immune Pharmaceuticals Provides Business and R&D Update and Announces First Quarter 2016 Financial Results

May 17, 2016

NEW YORK, May 16, 2016 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP) (“Immune” or the “Company”) announced financial results for the first quarter ended March 31, 2016. Business and Research & Development (“R&D”) Update Immune continues to pursue its strategy to unlock the value of its diversified pipeline through the development, financing and strategic partnering of…

Search

RECENT PRESS RELEASES

Related Post

California considers climate superfund bill to hold fossil fuel firms accountable

California considers climate superfund bill to hold fossil fuel firms accountable

January 15, 2025|0 Comments
How did the Palisades Fire start? Residents point to New Year’s Day blaze in same area
How did the Palisades Fire start? Residents point to New Year’s Day blaze in same area
Gallery

How did the Palisades Fire start? Residents point to New Year’s Day blaze in same area

January 15, 2025|0 Comments
Inside Meta’s race to beat OpenAI: “We need to learn how to build frontier and win this race”
Inside Meta’s race to beat OpenAI: “We need to learn how to build frontier and win this race”
Gallery

Inside Meta’s race to beat OpenAI: “We need to learn how to build frontier and win this race”

January 15, 2025|0 Comments
Meta just flipped the switch that prevents misinformation from spreading in the United States
Meta just flipped the switch that prevents misinformation from spreading in the United States
Gallery

Meta just flipped the switch that prevents misinformation from spreading in the United States

January 15, 2025|0 Comments